Catalyst Wire Dossier Catalyst Wire Dossier

PRX-112

· Protalix Biotherapeutics
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PRX-112, covering 2014-04-07 to 2016-09-28. Get the full timeline:

Most recent: Clinical Trial Update: An Open-Label, Dose Escalation Study to Evaluate the Safety and the Pharmacokinetics of Oral PRX-112 [Phase 2]

See pricing